Dortmund

The site in Dortmund plays a key role in manufacturing the propellant-free inhaler RESPIMAT® as well as all other products within the RESPIMAT® portfolio. Every year, the Boehringer Ingelheim microParts GmbH produces up to 45 million inhalation devices at this site with its more than 600 employees.

In 2004, Boehringer Ingelheim acquired the Dortmund-based company Steag microParts, which has been known as the Boehringer Ingelheim microParts GmbH ever since. Serial production of the RESPIMAT® had already started in 2002. As part of the global production network of Boehringer Ingelheim, the Dortmund site is responsible for the manufacture of the RESPIMAT® inhaler, which is then packaged with its cartridges in Ingelheim, Germany, and Sant Cugat, Spain.

With the advent of the RESPIMAT® re-usable in 2019, this product is also now available in an environmental-friendly reusable variant. Since 2020, the Dortmund site also manufactures the core elements for the Aservo® EquiHaler®, an inhalation therapy for horses, which is based on the RESPIMAT® technology.